对 cuproptosis 诱导剂和抑制剂的新见解
Ligang Zhang1,2, Ruiting Deng3, Lian Liu1
1Gene Editing Technology Center of Guangdong Province, School of Medicine, Foshan University, Foshan, China.
Frontiers in molecular biosciences
|December 11, 2024
概括
质亡是一种新的细胞死亡途径,涉及铜依赖蛋白质的聚合和压力. 了解它的目标和途径有助于开发各种疾病的治疗方法.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 型亡是一种新发现的细胞死亡机制,依赖于铜 (Cu).
- 它的特点是脂质化蛋白聚合,Fe-S集群损失和氧化应激增加.
- 之前对铜恒温和细胞死亡途径的研究为发现铜亡奠定了基础.
研究的目的:
- 为了阐明代谢途径和cuproptosis的关键目标.
- 探索cuproptosis在遗传,神经退行性,心血管和瘤疾病中的作用.
- 为了分类 cuproptosis 诱导剂和抑制剂用于治疗开发.
主要方法:
- 对cuproptosis的现有文献进行审查和分类.
- 在cuproptosis代谢途径 (氧化应激,线粒体呼吸,ubiquitin-proteasome系统) 中确定关键目标.
- 根据这些目标对诱导剂和抑制剂进行分类.
主要成果:
- cuproptosis涉及TCA循环中的异常脂质化蛋白聚合.
- 关键目标与氧化应激,线粒体呼吸和无素-蛋白酶体系统有关.
- 小分子,转录因子和ncRNA被确定为潜在的诱导剂/抑制剂.
结论:
- 质亡代表着一种独特的细胞死亡途径,对疾病有重大影响.
- 针对cuproptosis途径提供了潜在的治疗策略.
- 对cuproptosis目标和调节器的进一步研究对于未来的医学应用至关重要.
更多相关视频
05:19Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
Published on: December 1, 2023
938
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.3K
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
